Skip to main navigation
Skip to search
Skip to main content
Prince Sattam bin Abdulaziz University Home
Search content at Prince Sattam bin Abdulaziz University
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Dishevelled: An emerging therapeutic oncogene in human cancers
Shadia Hamoud Alshahrani
, Nodir Rakhimov
, Arti Rana
, Hashem O. Alsaab
,
Ahmed Hjazi
, Mohaned Adile
, Munther Abosaooda
, Adeeb Abdulally Abdulhussien Alazbjee
, Ali Alsalamy
, Reza Mahmoudi
Medical Laboratory Sciences
King Khalid University
Samarkand State Medical University
Tashkent State Medical University
Uttaranchal University
Taif University
Al-Farahidi University
The Islamic University, Najaf
Al-Ayen University
Imam Ja'afar Al-Sadiq University
Tehran University of Medical Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dishevelled: An emerging therapeutic oncogene in human cancers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Malignant Neoplasm
100%
Cancer
100%
Oncogene
100%
Mediator
33%
Neoplasm
16%
Diseases
16%
Programmed Cell Death
16%
Biological Marker
16%
Cell Invasion
16%
Cell Proliferation
16%
Cell Cycle
16%
Cell Signaling Pathway
16%
Cancer Growth
16%
Drug Resistance
16%
Cancer Diagnosis
16%
Carcinogenesis
16%
Fluorouracil
16%
Lymph Node Metastasis
16%
Cancer Chemotherapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Diseases
14%
Biological Marker
14%
Neoplasm
14%
Paclitaxel
14%
Fluorouracil
14%
Drug Resistance
14%
Cancer Growth
14%
Methotrexate
14%
Molecular Target
14%
Carcinogenesis
14%
Lymph Node Metastasis
14%
Cancer Chemotherapy
14%
Catenin
14%
Biochemistry, Genetics and Molecular Biology
Oncogene
100%
Wnt Signaling Pathway
25%
Mediator
25%
Programmed Cell Death
12%
Cell Proliferation
12%
Cell Cycle
12%
Cell Invasion
12%
Transcription
12%
Carcinogenesis
12%
Mesenchymal-Epithelial Transition
12%
Fluorouracil
12%
Catenin
12%
Drug Resistance
12%